Positron emission tomography using TSPO ligands as markers of microglial activation have been investigated for use in neurodegenerative diseases and multiple sclerosis [204,205], and are under investigation for prediction and monitoring of disease progression [203,206]. This evidence concerns the gene TSPO and multiple sclerosis.